PhillyPharma Archive: June, 2012

Bristol-Myers Squibb pays $5.3 billion for Amylin, makes deal with AstraZeneca

Comment icon 0 Comments
Bristol-Myers Squibb announced Friday night that it has agreed to buy San Diego-based Amylin Pharmaceuticals for $5.3 billion and then struck... Read more

Supreme Court reaction varies by profit and benefit potential

Comment icon 0 Comments
The Supreme Court's decision Thursday to uphold most of the Patient Protection and Affordable Care Act means different things to different... Read more

Supreme Court upholds ACA and Pharma can 'exhale'

Comment icon 0 Comments
The Supreme Court upheld most of the Patient Protection and Affordable Care Act by a 5-4 vote and a link to the decision is here. The main... Read more

Supreme Court predictions and opinions on disclosing payments to doctors

Comment icon 0 Comments
The Physician Payments Sunshine Act is part of the Patient Protection and Affordable Care Act, all of which hangs in the balance Thursday... Read more

FDA funding is odd, angst-ridden and ... bipartisan

Comment icon 0 Comments
The funding process for the U.S. Food and Drug Administration is odd, no less so because it sometimes leads to rare Congressional bipartisanship... Read more

Drug shortages are about quality, but also about price

Comment icon 0 Comments
If you are a patient or parent who can't get medicine you or your child needs to survive or live better, business profit prospects and government... Read more

Drug Information Association gathers at Philly Convention Center

Comment icon 0 Comments
The Horsham-based Drug Information Association will hold its 48th annual meeting beginning Monday morning at the Philadelphia Convention Center The... Read more

KPMG pharma survey shows angst among executives; job prospects murky

Comment icon 0 Comments
One finding in KPMG's latest survey of pharmaceutical executives in a way reflects the conundrum of efforts to fix health care in America:... Read more